Lawwly

Association for Molecular Pathology v. Myriad Genetics, Inc.

United States Supreme Court

133 S.Ct. 2107 (2013)

Relevant factsFree

Myriad (defendant) discovered the location of breast-cancer-related genes and patented both the isolated genes themselves and synthetically created complementary DNA (cDNA) derived from them; Dr. Ostrer (plaintiff) sought a declaration invalidating Myriad's patents.

IssueFree

Whether a naturally occurring DNA segment is patentable merely because it has been isolated.

Unlock the full brief

Free accounts read 20 full briefs. No card required.

Related cases